Inventor

GALEMMO JR ROBERT A

US26 patents

⚠️ This page may combine multiple inventors who share the name “GALEMMO JR ROBERT A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GALEMMO JR ROBERT A

RORER PHARMACEUTICAL CORP

Quinoline derivatives and use thereof as antagonists of leukotriene D4

Quinoline derivatives and use thereof as antagonists of leukotriene D4

Quinoline derivatives and use thereof as antagonists of leukotriene d4

Quinoline derivatives and use thereof as antagonists of leukotriene D4

Quinolinyl-chromone derivatives and use for treatment of hypersensitive ailments

3- and 5-(bicyclic ether or bicyclic alkylene thioether) alkylene amino thiatriazines

3- and 5-(bicyclic ether or bicyclic alkylene thioether) alkylene amino thiatriazines, and their pharmaceutical uses

RHONE POULENC RORER PHARMA

Substituted naphthylene compounds exhibiting selective leukotriene B4 antagonist activity

Quinoline derivatives and their use as antagonists of leukotriene d4

Quinoline derivatives as antagonists of leukotriene D4

Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity

Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity

Quinoline derivatives as antagonists of leukotriene D4

Quinoline derivatives as antagonists of leukotriene d4

CORTEXYME INC

Aminopyridine compounds and methods for the preparation and use thereof

Ketone inhibitors of lysine gingipain

Ketone inhibitors of lysine gingipain

Ketone inhibitors of lysine gingipain

(unassigned)

Inhibitors of factor Xa with a neutral P1 specificity group

BRISTOL MYERS SQUIBB PHARMA CO

Nitrogen containing heteroaromatics with ortho-substituted P1&#39;s as factor Xa inhibitors

DU PONT PHARM CO

Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitors

RORER PHARAMCEUTICAL CORP

Quinoline derivatives and use thereof as antagonists of leukotriene D4

JANSSEN PHAMACEUTICA N V

N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders

JANSSEN PHARMACEUTICA NV

N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders

SOUTHERN RES INST

Triazolopyridazine compounds, use as inhibitors of the kinase LRRK2, and methods for preparation thereof

VERGE ANALYTICS INC

Substituted pyrazolo-pyrimidines and uses thereof

Nitrogen containing heteroaromatics with ortho-substituted P1's as factor Xa inhibitors